Abbott Laboratories (ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	217,498	196,184	191,088	191,427	241,365	187,600
Market Cap Growth	7.06%	2.67%	-0.18%	-20.69%	28.66%	22.13%
Enterprise Value	222,740	203,674	199,953	198,309	250,286	201,641
Last Close Price	125.08	111.01	105.91	103.57	130.57	100.03
PE Ratio	15.71	14.69	33.52	27.72	34.28	41.94
Forward PE	22.60	22.39	24.22	26.64	30.05	23.93
PS Ratio	4.97	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.27	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.17	10.96	31.28	55.76	-	-
P/FCF Ratio	31.44	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	23.85	22.92	26.32	19.98	22.92	23.74
PEG Ratio	2.34	2.61	2.85	5.16	2.38	2.06
EV/Sales Ratio	5.08	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	18.96	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	25.85	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	32.20	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.25	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.07	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	1.88	2.41	3.16	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.84	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.09	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.70	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.62%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.79%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	9.03%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	12.40%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.40%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	3.18%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.89%	2.02%	1.96%	1.85%	1.39%	1.53%
Payout Ratio	29.65%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.04%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	1.93%	2.08%	2.81%	3.25%	1.23%	1.25%

Updated Oct 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q